Patrick Wood
Stock Analyst at Morgan Stanley
(2.85)
# 1,888
Out of 5,033 analysts
105
Total ratings
43.59%
Success rate
0.51%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Equal-Weight | $84 → $76 | $74.99 | +1.35% | 6 | Aug 28, 2025 | |
| ALC Alcon | Maintains: Equal-Weight | $84 → $80 | $75.46 | +6.02% | 5 | Aug 21, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $196 → $197 | $191.00 | +3.14% | 5 | Aug 11, 2025 | |
| STE STERIS | Maintains: Overweight | $276 → $295 | $242.22 | +21.79% | 7 | Aug 8, 2025 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $115 → $123 | $119.90 | +2.59% | 2 | Aug 1, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $12 → $13 | $15.75 | -17.46% | 8 | Aug 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $78 → $74 | $75.48 | -1.96% | 7 | Jul 31, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $71 → $68 | $34.72 | +95.85% | 3 | Jul 15, 2025 | |
| EW Edwards Lifesciences | Maintains: Equal-Weight | $75 → $81 | $75.29 | +7.58% | 9 | Jul 15, 2025 | |
| DXCM DexCom | Maintains: Equal-Weight | $82 → $89 | $68.43 | +30.06% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $27 | $23.13 | +16.73% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $20 → $9 | $8.53 | +5.51% | 2 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $80 → $103 | $72.87 | +41.35% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $125 | $100.53 | +24.34% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $110 → $72 | $79.47 | -9.40% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $191 → $173 | $130.54 | +32.53% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $45 → $22 | $15.54 | +41.57% | 4 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $326.85 | -3.01% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $6.10 | +63.93% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $25.32 | +46.13% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $128.05 | - | 5 | Dec 11, 2017 |
The Cooper Companies
Aug 28, 2025
Maintains: Equal-Weight
Price Target: $84 → $76
Current: $74.99
Upside: +1.35%
Alcon
Aug 21, 2025
Maintains: Equal-Weight
Price Target: $84 → $80
Current: $75.46
Upside: +6.02%
Becton, Dickinson and Company
Aug 11, 2025
Maintains: Overweight
Price Target: $196 → $197
Current: $191.00
Upside: +3.14%
STERIS
Aug 8, 2025
Maintains: Overweight
Price Target: $276 → $295
Current: $242.22
Upside: +21.79%
TransMedics Group
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $115 → $123
Current: $119.90
Upside: +2.59%
Bausch + Lomb
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $15.75
Upside: -17.46%
GE HealthCare Technologies
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $78 → $74
Current: $75.48
Upside: -1.96%
PROCEPT BioRobotics
Jul 15, 2025
Maintains: Overweight
Price Target: $71 → $68
Current: $34.72
Upside: +95.85%
Edwards Lifesciences
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $75 → $81
Current: $75.29
Upside: +7.58%
DexCom
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $82 → $89
Current: $68.43
Upside: +30.06%
Jul 15, 2025
Maintains: Underweight
Price Target: $28 → $27
Current: $23.13
Upside: +16.73%
Jul 15, 2025
Downgrades: Equal-Weight
Price Target: $20 → $9
Current: $8.53
Upside: +5.51%
Jul 15, 2025
Upgrades: Overweight
Price Target: $80 → $103
Current: $72.87
Upside: +41.35%
May 16, 2025
Maintains: Overweight
Price Target: $120 → $125
Current: $100.53
Upside: +24.34%
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $79.47
Upside: -9.40%
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $130.54
Upside: +32.53%
Mar 5, 2025
Downgrades: Equal-Weight
Price Target: $45 → $22
Current: $15.54
Upside: +41.57%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $326.85
Upside: -3.01%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $6.10
Upside: +63.93%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $25.32
Upside: +46.13%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $128.05
Upside: -